Elutia (ELUT) Metrics: History & Chart

Elutia Inc(ELUT)

Biotechnology · Gaithersburg, MD

$0.81-0.01 (-1.78%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Elutia Inc

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

Gaithersburg, MD

26 employees

elutia.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: C. Randal Mills

View full financials

Third-Party DCF Estimate (FMP)	$0.14
Price Gap vs Third-Party Estimate	-82.81%

7D Total Return	+1.43%
30D Total Return	+0.05%
YTD Total Return	+18.61%
1Y Total Return	-6.64%
3Y Total Return	-36.31%
5Y Total Return	-87.44%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+18.61%
2025	-81.48%
2024	+73.15%
2023	-49.18%
2022	-32.54%
2021	-53.78%
2020

CAGR TTM	-6.61%
CAGR 3Y	-13.96%
CAGR 5Y	-33.96%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	0.87
PE Ratio Avg TTM	1.13
PE Ratio Avg 3Y	1.13
Current VS TTM Avg	-23.26%
Current VS 3Y Avg	-23.26%
Current VS 5Y Avg	-23.26%

All Metrics

ELUT Valuation Metrics

ELUT Stock Price Metrics

ELUT Dividend Metrics

ELUT Growth Rate Metrics

ELUT Discounted Cash Flow Metrics

ELUT Returns By Period

ELUT Yearly Returns

ELUT Average Annual Returns By Period (CAGR)

ELUT Revenue Metrics

ELUT PE Ratio Metrics

ELUT PS Ratio Metrics

ELUT PB Ratio Metrics

ELUT Price to Free Cash Flow Ratio Metrics

ELUT Debt to Equity Ratio Metrics

ELUT PEG Ratio Metrics

ELUT FCF Yield

ELUT Earnings Yield

ELUT EBITDA Yield

ELUT OCF Yield

ELUT EV/EBIT Ratio Metrics

ELUT EV/EBITDA Ratio Metrics

ELUT EV/Assets Ratio Metrics

ELUT EV/Sales Ratio Metrics

ELUT Current Ratio Metrics

ELUT Quick Ratio Metrics

ELUT ROIC Metrics

ELUT Return on Assets Metrics

ELUT Return on Equity Metrics

ELUT Net Profit Margin Metrics

ELUT Gross Profit Margin Metrics

ELUT Tax Rate Metrics

PS Ratio	2.95
PS Ratio Avg TTM	2.34
PS Ratio Avg 3Y	2.87
Current VS TTM Avg	+26.21%
Current VS 3Y Avg	+2.62%
Current VS 5Y Avg	+21.44%

PB Ratio	2.28
PB Ratio Avg TTM	1.97
PB Ratio Avg 3Y	1.97
Current VS TTM Avg	+15.46%
Current VS 3Y Avg	+15.46%
Current VS 5Y Avg	+15.46%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.69
Debt/Equity Ratio Avg TTM	(0.05)
Debt/Equity Ratio Avg 3Y	(0.60)
Current VS TTM Avg	+1422.01%
Current VS 3Y Avg	+215.12%
Current VS 5Y Avg	+272.85%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	114.41%
Earnings Yield Avg TTM	90.36%
Earnings Yield Avg 3Y	90.36%
Current VS TTM Avg	+26.62%
Current VS 3Y Avg	+26.62%
Current VS 5Y Avg	+26.62%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.61
Ev/Assets Ratio Avg TTM	1.09
Ev/Assets Ratio Avg 3Y	1.76
Current VS TTM Avg	-43.90%
Current VS 3Y Avg	-65.40%
Current VS 5Y Avg	-62.21%

Ev/Sales Ratio	2.20
Ev/Sales Ratio Avg TTM	1.98
Ev/Sales Ratio Avg 3Y	2.99
Current VS TTM Avg	+10.87%
Current VS 3Y Avg	-26.34%
Current VS 5Y Avg	-17.14%

Current Ratio	1.77
Current Ratio Avg TTM	1.41
Current Ratio Avg 3Y	0.73
Current VS TTM Avg	+25.09%
Current VS 3Y Avg	+141.73%
Current VS 5Y Avg	+55.47%

Quick Ratio	1.64
Quick Ratio Avg TTM	1.31
Quick Ratio Avg 3Y	0.62
Current VS TTM Avg	+25.58%
Current VS 3Y Avg	+164.59%
Current VS 5Y Avg	+82.31%

ROIC	(79.27%)
ROIC Avg 3Y	(337.61%)
ROIC Avg 5Y	(266.48%)
Current VS 3Y Avg	+76.52%
Current VS 5Y Avg	+70.25%
Current VS 10Y Avg	+70.25%

ROA	118.69%
ROA Avg TTM	8.19%
ROA Avg 3Y	(16.46%)
Current VS TTM Avg	+1349.26%
Current VS 3Y Avg	+820.98%
Current VS 5Y Avg	+821.16%

ROE	329.02%
ROE Avg TTM	247.73%
ROE Avg 3Y	247.73%
Current VS TTM Avg	+32.81%
Current VS 3Y Avg	+32.81%
Current VS 5Y Avg	+32.81%

Net Profit Margin	426.93%
Net Profit Margin Avg TTM	267.89%
Net Profit Margin Avg 3Y	(162.51%)
Current VS TTM Avg	+59.37%
Current VS 3Y Avg	+362.71%
Current VS 5Y Avg	+443.84%

Gross Profit Margin	57.82%
Gross Pft Margin Avg TTM	56.12%
Gross Pft Margin Avg 3Y	47.88%
Current VS TTM Avg	+3.03%
Current VS 3Y Avg	+20.77%
Current VS 5Y Avg	+27.90%

Tax Rate	0.62%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A